Ekso Indego Therapy vs Laevo V2
Side-by-side comparison of Ekso Indego Therapy (Ekso Bionics) and Laevo V2 (Laevo) — specs, pricing, Robo Index, and verified deployments. Updated daily.
Optimize comparison for buyer
Layer 1: Identity & Trust
Manufacturer Country
- Ekso Indego TherapyUnited States

- Laevo V2Netherlands

Year First Available
- Ekso Indego Therapy2016

- Laevo V22015

Verified Deployments
- Ekso Indego Therapy0 Deployments

- Laevo V20 Deployments

Layer 2: Operational
Battery / Shift Runtime
- Ekso Indego Therapy6 hrs

- Laevo V2—

Availability Status
- Ekso Indego TherapyACTIVE

- Laevo V2ACTIVE

Layer 3: Category Specific
![]() | ||
|---|---|---|
| Layer 1: Identity & Trust | ||
| Manufacturer Country (values differ) | United States | Netherlands |
| Year First Available (values differ) | 2016 | 2015 |
| Verified Deployments | 0 Deployments | 0 Deployments |
| Layer 2: Operational | ||
| Battery / Shift Runtime (values differ) | 6 hrs | — |
| Availability Status | ACTIVE | ACTIVE |
| Layer 3: Category Specific | ||
Insufficient data for full comparison
The following fields had no data for any of the selected robots: Price, Payload Capacity, Reach, Max Speed, IP Rating, Autonomy Level
ROI Comparison
Same operating assumptions across every robot — the only difference is price. Set your numbers once to see which pays back fastest.
Annual labor displaced (per robot): $50,000
| Metric | Ekso Indego Therapy | Laevo V2 |
|---|---|---|
| Investment | No price | No price |
| Payback period | — | — |
| Net savings (5 yr) | — | — |
| ROI (5 yr) | — | — |
Ekso Indego Therapy, Laevo V2 have no listed price, so payback can't be computed. Contact the manufacturer for a quote.
Estimates labor-cost displacement only — not a full total cost of ownership. Actual ROI depends on integration, maintenance, training, downtime, and task fit. Converted currencies are indicative; USD is the price of record.
Trade-offs at a glance
Frequently asked
Who makes Ekso Indego Therapy and Laevo V2?
Ekso Indego Therapy is made by Ekso Bionics, based in US. Laevo V2 is made by Laevo, based in NL.
When were Ekso Indego Therapy and Laevo V2 launched?
Ekso Indego Therapy launched in 2016. Laevo V2 launched in 2015.
How do Ekso Indego Therapy and Laevo V2 compare on the Robo Index?
Ekso Indego Therapy grades AA on the Robo Index. Laevo V2 grades A. The Robo Index is a credibility grade (AAA … C) that blends commercial maturity, verified deployments, company standing, and independent coverage — see methodology for the full breakdown.
Are Ekso Indego Therapy and Laevo V2 in the same category?
Both robots are classified as Exoskeleton on Robolist. Filters and ranking treat them as direct alternatives.
What is the realistic total cost of ownership for Exoskeleton robots?
Hardware cost is one input. Exoskeleton TCO also includes integration, training, downtime, and end-of-life. Our breakdown: The real cost and payback of an industrial exoskeleton program.
What should a buyer ask vendors when choosing between Ekso Indego Therapy and Laevo V2?
Spec sheets only show part of the story. Useful vendor questions cover support, lifecycle, integration cost, and references. We have a buyer-focused checklist: The exoskeleton vendor RFP: questions and red flags.
Going deeper — picking the right robot
The real cost and payback of an industrial exoskeleton program
7 min readExoskeletons
The exoskeleton vendor RFP: questions and red flags
8 min readExoskeletons
A 90-day deployment playbook for industrial exoskeleton programs
9 min readExoskeletons
Build vs buy vs lease: which model fits a first deployment
8 min readChoosing Your First Robot
The hidden specs vendors hope you'll miss
10 min readReading the Spec Sheet
Want to be notified when specs or pricing change for these robots? Drop your email.
Other comparisons
About this comparison
Ekso Indego Therapy vs Laevo V2 compares two robots in the exoskeleton category. All data is sourced from manufacturer spec sheets, verified deployments, and third-party filings; see our methodology for how the Robo Index is calculated.